Board of Scientific Counselors, National Center for Infectious Diseases (NCID): Meeting, 7659-7660 [E7-2753]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 32 / Friday, February 16, 2007 / Notices
other forms of information technology to
minimize the information collection
burden.
Type of Information Collection
Request: New collection;
Title of Information Collection:
External Evaluation of National Centers
of Excellence in Women’s Health
Program;
Form/OMB No.: 0990–New;
Use: This evaluation will assess the
effectiveness of the National Centers of
Excellence in Women’s Health Program
contracts. Specifically, the outcomesbased research question will ask:
‘‘Overall, do women seen at CoEs
perceive their clinical care to be better
than those who receive healthcare
elsewhere?’’ Outreach surveys will
assess community impacts.
Frequency: One-time on Occasion;
Affected Public: Individuals or
Households;
Annual Number of Respondents:
6800;
Total Annual Responses: 6800;
Average Burden per Response: 12.65
minutes;
Total Annual Hours: 1433;
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, e-mail your request,
including your address, phone number,
OMB number, and OS document
identifier, to
Sherette.funncoleman@hhs.gov, or call
the Reports Clearance Office on (202)
690–6162. Written comments and
recommendations for the proposed
information collections must be
received within 30 days of this notice
directly to the Desk Officer at the
address below: OMB Desk Officer: John
Kraemer, OMB Human Resources and
Housing Branch, Attention: (OMB
#0990–New), New Executive Office
Building, Room 10235, Washington, DC
20503.
Dated: February 9, 2007.
Alice Bettencourt,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. E7–2769 Filed 2–15–07; 8:45 am]
BILLING CODE 4150–33–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, National Center for
HIV, STD, and TB Prevention, 1600
Clifton Road, NE., M/S E–07, Atlanta,
Georgia 30333, telephone (404) 639–
8317.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention
[FR Doc. E7–2766 Filed 2–15–07; 8:45 am]
Centers for Disease Control and
Prevention
sroberts on PROD1PC70 with NOTICES
Control and Prevention (CDC)
announces the following council
meeting of the aforementioned
committee.
Times and Dates: 8:30 a.m.–5 p.m.,
March 20, 2007. 8:30 a.m.–2 p.m.,
March 21, 2007.
Place: Corporate Square, Building 8,
1st Floor Conference Room, Atlanta,
Georgia 30333, telephone (404) 639–
8317.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 100
people.
Purpose: This council advises and
makes recommendations to the
Secretary, Health and Human Services,
the Assistant Secretary for Health, and
the Director, CDC, regarding the
elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives,
and priorities; addresses the
development and application of new
technologies; and reviews the extent to
which progress has been made toward
eliminating tuberculosis.
Matters to be Discussed: Agenda items
include issues pertaining to TB
Disparities in African Americans;
Response to Control Extensively Drug
Resistant Tuberculosis in the U.S.; and
U.S.-Mexico Border Issues and other
related tuberculosis issues.
Agenda items are subject to change as
priorities dictate.
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
BILLING CODE 4163–18–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
VerDate Aug<31>2005
19:03 Feb 15, 2007
Jkt 211001
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
7659
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Infectious Diseases
(NCID): Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee.
Times and Dates: 9 a.m.–5:30 p.m.,
March 15, 2007; 8:30 a.m.–2:30 p.m.,
March 16, 2007.
Place: CDC, Building 19, 1600 Clifton
Road, N.E., Atlanta, Georgia 30333.
Status: Open to the public, limited
only by the space available.
Purpose: The Board of Scientific
Counselors, NCID, provides advice and
guidance to the Director, CDC, and
Director, NCID, in the following areas:
program goals and objectives; strategies;
program organization and resources for
infectious disease prevention and
control; and program priorities.
Matters To Be Discussed: Agenda
items will include:
1. Breakout Group Discussions:
Vaccine Preventable Disease
Surveillance
Respiratory Outbreaks
Ecology of Emerging Zoonoses and
Other Infectious Diseases
Food-Borne Diseases: The New Way
Forward
Working with Academic Partners
Chlamydia Screening Programs in the
U.S.
Antimicrobial Resistance
Infectivity Component of Infection
Control
Exotic Animal Importation and Trade
2. Coordinating Center for Infectious
Diseases Updates
3. Strategies for Identifying New
Pathogens
Other agenda items include
announcements/introductions; followup on actions recommended by the
Board in May 2006; consideration of
future directions, goals, and
recommendations.
Agenda items are subject to change as
priorities dictate.
Written comments are welcome and
should be received by the contact
person listed below prior to the opening
of the meeting.
FOR FURTHER INFORMATION CONTACT:
Tony Johnson, Office of the Director,
NCID, CDC, Mailstop A–45, 1600 Clifton
Road, NE, Atlanta, Georgia 30333, email tjohnson3@cdc.gov; telephone 404/
639–3856.
E:\FR\FM\16FEN1.SGM
16FEN1
7660
Federal Register / Vol. 72, No. 32 / Friday, February 16, 2007 / Notices
The Director, Management Analysis
and Services office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0509. The
approval expires on January 31, 2010. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.fda.gov/
ohrms/dockets.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–2753 Filed 2–15–07; 8:45 am]
Dated: February 9, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–2708 Filed 2–15–07; 8:45 am]
BILLING CODE 4160–01–S
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food and Drug Administration
[Docket No. 2006N–0435]
[Docket No. 2006N–0274]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Establishing and Maintaining a List of
United States Dairy Product
Manufacturers/Processors With
Interest in Exporting to Chile
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Guidance for
Industry on How to Use E-Mail to
Submit a Notice of Intent to Slaughter
for Human Food Purposes
AGENCY:
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Establishing and Maintaining a List of
U.S. Dairy Product Manufacturers/
Processors with Interest in Exporting to
Chile’’ has been approved by the Office
of Management and Budget (OMB)
under the Paperwork Reduction Act of
1995.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
SUPPLEMENTARY INFORMATION: In the
Federal Register of December 7, 2006
(71 FR 70972), the agency announced
that the proposed information collection
had been submitted to OMB for review
and clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
SUMMARY:
Food and Drug Administration,
HHS.
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by March 19,
2007.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
1472.
In
compliance with 44 U.S.C. 3507, FDA
SUPPLEMENTARY INFORMATION:
has submitted the following proposed
collection of information to OMB for
review and clearance:
Guidance for Industry on ‘‘How to Use
E-mail to Submit a Notice of Intent to
Slaughter for Human Food Purposes,’’
Section 512j, Federal Food, Drug, and
Cosmetic Act; (OMB Control Number
0910–0450)—Extension
Section 512(j) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C.
360b(j)) gives FDA the authority to set
conditions under which animals treated
with investigational new animal drugs
may be marketed for food use. Under
this authority, the Center for Veterinary
Medicine (CVM), issues to a new animal
drug sponsor (sponsors) a slaughter
authorization letter that sets the terms
under which investigational animals
may be slaughtered. The United States
Department of Agriculture (USDA) also
monitors the slaughter of animals
treated with investigational new animal
drugs under the authority of the Meat
Inspection Act (21 USC 601–95).
Sponsors must submit slaughter notices
each time investigational animals are
presented for slaughter, unless this
requirement is waived by an
authorization letter (21 CFR 511.1(b)(5),
9 CFR 309.17). These notifications assist
CVM and USDA in monitoring the
safety of the food supply. Slaughter
notices were previously submitted to
CVM and USDA on paper (OMB No.
0910–0450). CVM’s guidance on ‘‘How
to Use E-Mail to Submit a Notice of
Intent to Slaughter for Human Food
Purposes’’ provides sponsors with the
option to submit a slaughter notice as an
e-mail attachment to CVM and USDA
via the Internet. The electronic
submission of slaughter notices is part
of CVM’s ongoing initiative to provide
a method for paperless submissions.
In the Federal Register of November
8, 2006 (71 FR 65532), FDA published
a 60-day notice soliciting comments on
the information collection provisions of
this collection. In response to this
notice, no comments were received.
The likely respondents for this
collection of information are new
animal drug sponsors.
FDA estimates the burden of this
collection of information as follows:
sroberts on PROD1PC70 with NOTICES
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
Form No.
No. of
Respondents
FDA Form #3488
1There
Annual Frequency
per Response
25
.08
Total Annual
Responses2
Hours per
Response
2
0.41
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Aug<31>2005
19:03 Feb 15, 2007
Jkt 211001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
E:\FR\FM\16FEN1.SGM
Total Hours
16FEN1
.82
]]>Agencies
[Federal Register Volume 72, Number 32 (Friday, February 16, 2007)]
[Notices]
[Pages 7659-7660]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-2753]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Infectious
Diseases (NCID): Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee.
Times and Dates: 9 a.m.-5:30 p.m., March 15, 2007; 8:30 a.m.-2:30
p.m., March 16, 2007.
Place: CDC, Building 19, 1600 Clifton Road, N.E., Atlanta, Georgia
30333.
Status: Open to the public, limited only by the space available.
Purpose: The Board of Scientific Counselors, NCID, provides advice
and guidance to the Director, CDC, and Director, NCID, in the following
areas: program goals and objectives; strategies; program organization
and resources for infectious disease prevention and control; and
program priorities.
Matters To Be Discussed: Agenda items will include:
1. Breakout Group Discussions:
Vaccine Preventable Disease Surveillance
Respiratory Outbreaks
Ecology of Emerging Zoonoses and Other Infectious Diseases
Food-Borne Diseases: The New Way Forward
Working with Academic Partners
Chlamydia Screening Programs in the U.S.
Antimicrobial Resistance
Infectivity Component of Infection Control
Exotic Animal Importation and Trade
2. Coordinating Center for Infectious Diseases Updates
3. Strategies for Identifying New Pathogens
Other agenda items include announcements/introductions; follow-up
on actions recommended by the Board in May 2006; consideration of
future directions, goals, and recommendations.
Agenda items are subject to change as priorities dictate.
Written comments are welcome and should be received by the contact
person listed below prior to the opening of the meeting.
FOR FURTHER INFORMATION CONTACT: Tony Johnson, Office of the Director,
NCID, CDC, Mailstop A-45, 1600 Clifton Road, NE, Atlanta, Georgia
30333, e-mail tjohnson3@cdc.gov; telephone 404/639-3856.
[[Page 7660]]
The Director, Management Analysis and Services office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-2753 Filed 2-15-07; 8:45 am]
BILLING CODE 4163-18-P
